biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Where are all our wonderful posters

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Jul 18, 2023 7:44pm

181 Views

Post# 35547053

RE:Where are all our wonderful posters

ronrydell wrote: We still are on life support but the plug hasn't been pulled yet. Will we see August? What's the latest on J@J? Any updates on the great compound x et Al?

Its so quiet because Johnny boy is doing all his "readin and studyn".

Connecting all the Dots!

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale